Wolverine World Wide, Inc., and Brooks Shoe, Inc. v. Nike, Inc.

38 F.3d 1192, 1994 WL 540687
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 14, 1994
Docket94-1119
StatusPublished
Cited by78 cases

This text of 38 F.3d 1192 (Wolverine World Wide, Inc., and Brooks Shoe, Inc. v. Nike, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wolverine World Wide, Inc., and Brooks Shoe, Inc. v. Nike, Inc., 38 F.3d 1192, 1994 WL 540687 (Fed. Cir. 1994).

Opinion

*1194 SCHALL, Circuit Judge.

Wolverine World Wide, Inc. (Wolverine) appeals from the November 12, 1993 judgment of the United States District Court for the Western District of Michigan, No. 1:92:CV:886, granting summary judgment of non-infringement of U.S. Patent No. 4,736,-531 (the ’531 patent) in favor of Nike, Inc. (Nike). 1 We affirm.

BACKGROUND

Wolverine is the assignee of the ’531 patent, which is titled “Athletic Shoe for Aerobic Exercise and the Like.” The claims of the ’531 patent relate to an athletic shoe having an elastic “slipper sock” disposed within the shoe’s upper. According to the specification of the ’531 patent, the slipper sock keeps the shoe “in tune” with the wearer’s foot by “mov[ing] totally simultaneously with the foot, stretching momentarily away from the shoe as necessary, but almost immediately bringing the shoe into total conformity with the foot.” Col. 4, lines 23-27. In this manner, presumably, the object of the ’531 patent — “comfortable containment of the foot even during the abrupt lateral thrusts and extended vertical flexes experienced [during] vigorous activity,” col. 1, lines 56-58 — is achieved. Claims 1, 4, and 5 of the ’531 patent, the claims at issue on appeal, recite:

1. An athletic shoe for aerobic exercising and the like comprising:
a sole assembly;
an upper secured to said sole assembly, defining a foot-receiving cavity and having closure means for retention of the shoe on a foot;
a forefoot-enveloping and gripping, elastic slipper sock in said cavity encompassing the forepart of said cavity, said elastic slipper sock having a bottom anchored to said sole assembly and free to grip onto a foot in said cavity independent of said upper; and
an insole having a forward portion in said slipper sock on the inner upper surface of said slipper sock bottom.
4. The shoe in claim 1 wherein said elastic slipper sock bottom extends to the front of the heel and having its upper part over the instep region.
5. The shoe in claim 4 wherein said elastic slipper sock comprises a stretchable elastic fabric having a foam layer in the instep region to serve also as a shoe tongue.

Wolverine brought suit in the district court alleging that several of Nike’s shoes — i.e., all of Nike’s “Huarache” line of shoes and those of the “Air” line that contain the “Dynamic Fit” component — infringe claims 1, 4, and 5 of the ’531 patent, either literally or under the doctrine of equivalents. In due course, Nike moved for summary judgment that its shoes did not infringe the ’531 patent. The dispute in the district court centered on the meaning of the third clause of claim 1 — a “forefoot-enveloping and gripping, elastic slipper sock” — and its presence vel non in the accused shoes. Both lines of accused shoes include what Nike refers to as an “inner sleeve.” In the Huarache shoe, shown below, the inner sleeve envelops the wearer’s ankle and heel regions, and extends over the top of the instep, below the laces.

*1195 [[Image here]]

The Dynamic Fit shoe, shown below, employs an inner sleeve shaped somewhat like an addition symbol, which envelops the wearer’s instep but not the wearer’s ankle or heel.

[[Image here]]

It is undisputed that the inner sleeves in the accused shoes do not encompass the wearer’s toes.

Relying on the ’531 patent specification, the district court interpreted the disputed term in claim 1, “forefoot-enveloping,” as limiting the claimed slipper sock to one that envelops the wearer’s toes, thereby precluding literal infringement by Nike’s shoes, which have toeless inner sleeves. In addition, the district court interpreted other language of the disputed clause — “said elastic slipper sock ... free to grip onto a foot in said cavity independent of said upper” — as requiring the slipper sock to be “substantially unattached to said shoe upper.” 2 Concluding that the degree of attachment in the accused shoes was, as a matter of law, too significant to be characterized as “substantially unattached,” the district court held that *1196 the absence of this limitation alternatively precluded a finding of literal infringement. Lastly, the district court interpreted the term “elastic” to exclude Nike’s inner sleeves from the literal scope of claim 1. Nike’s inner sleeves are made from neoprene with a lycra liner. With regard to the doctrine of equivalents, the district court concluded that the claimed and accused shoes' lacked substantial identity in both function and the way in which the function is performed. Accordingly, the district court granted Nike’s motion for summary judgment that its accused shoes did not infringe the ’531 patent, either literally or under the doctrine of equivalents.

DISCUSSION

A.

A grant of summary judgment is appropriate where “there is no genuine issue as to any material fact and ... the moving party is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(c); Johnston v. IVAC Corp., 885 F.2d 1574, 1576-77, 12 USPQ2d 1382, 1383 (Fed.Cir.1989). In other words, summary judgment is appropriately granted in favor of the moving party where no “reasonable jury could return a verdict for the nonmoving party.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 2510, 91 L.Ed.2d 202 (1986). We review a district court’s grant of summary judgment de novo. Conroy v. Reebok Int’l, Ltd., 14 F.3d 1570, 1575, 24 USPQ2d 1373, 1377 (Fed.Cir.1994). Thus, in deciding whether the district court properly granted summary judgment of non-infringement, we must decide for ourselves whether a reasonable fact-finder could find that Nike’s accused shoes infringed the ’531 patent. See London v. Carson Pirie Scott & Co., 946 F.2d 1534, 1538, 20 USPQ2d 1456, 1458 (Fed.Cir.1991).

Determining whether a patent claim is infringed requires a two-step inquiry: “First, the claim must be properly construed to determine its scope and meaning. Second, the claim as properly construed must be compared to the accused device.... ” Carroll Touch, Inc. v. Electro Mechanical Sys., 15 F.3d 1573, 1576, 27 USPQ2d 1836, 1839 (Fed.Cir.1993). In the first step, construing the claim, unless the specification or the file history indicates that the inventor intended otherwise, a claim term will be accorded its ordinary and accustomed meaning. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Solutran, Inc. v. U.S. Bancorp
291 F. Supp. 3d 877 (D. Maine, 2017)
Paone v. Microsoft Corp.
881 F. Supp. 2d 386 (E.D. New York, 2012)
Brocade Communications Systems, Inc. v. A10 Networks, Inc.
843 F. Supp. 2d 1018 (N.D. California, 2012)
Chet's Shoes, Inc. v. Kastner
710 F. Supp. 2d 436 (D. Vermont, 2010)
MHL TEK, LLC v. Nissan Motor Co.
691 F. Supp. 2d 698 (E.D. Texas, 2010)
CLEARWATER SYSTEMS CORP. v. Evapco, Inc.
596 F. Supp. 2d 291 (D. Connecticut, 2009)
Lucent Technologies, Inc. v. Microsoft Corp.
544 F. Supp. 2d 1080 (S.D. California, 2008)
Bradford Co. v. AFCO Manufacturing
628 F. Supp. 2d 756 (S.D. Ohio, 2007)
Diomed, Inc. v. AngioDynamics, Inc.
450 F. Supp. 2d 130 (D. Massachusetts, 2006)
Terlep v. The Brinkmann Corp.
418 F.3d 1379 (Federal Circuit, 2005)
PRO-TECH WELDING AND FABRICATION INC. v. Lajuett
367 F. Supp. 2d 398 (W.D. New York, 2005)
Giantceutical, Inc. v. Ken Mable, Inc.
356 F. Supp. 2d 374 (S.D. New York, 2005)
NPC v. International Precast Supply
2004 DNH 142 (D. New Hampshire, 2004)
NPC, Inc. v. International Precast Supply, Inc.
337 F. Supp. 2d 378 (D. New Hampshire, 2004)
Aventis Pharmaceuticals, Inc. v. Barr Laboratories, Inc.
335 F. Supp. 2d 558 (D. New Jersey, 2004)
Bristol-Myers Squibb Co. v. Andrx Pharmaceuticals, Inc.
343 F. Supp. 2d 1124 (S.D. Florida, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
38 F.3d 1192, 1994 WL 540687, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wolverine-world-wide-inc-and-brooks-shoe-inc-v-nike-inc-cafc-1994.